期刊文献+

CX40和miR-155在冠状动脉粥样硬化性心脏病猝死者心肌中的表达及其法医学意义 被引量:4

Expression and significance of CX40 and miR-155 in the patients of sudden coronary death
下载PDF
导出
摘要 目的鉴定在冠状动脉粥样硬化性心脏病猝死者心肌中心肌连接蛋白(connexin,CX)40、免疫及炎症相关的小分子RNA(micro155)的表达及探讨其法医病理学意义。方法在2014-2015年间法医尸体解剖工作中选出22例符合冠心病猝死的心脏标本(标本严格按照冠状动脉粥样硬化性心脏病的标准进行筛选)作为试验组,再选取10例非冠心病猝死者作为对照组;对筛选出两组中所有的蜡块进行连续切片,HE染色;利用免疫组织化学染色来检测CX40在心肌中的表达;蜡块心肌组织中提取micr RNA,利用RT-PCR法检测每组中mi R-155的表达情况;数据统计学处理采用SPSS18.0统计软件分析,P<0.05为差异有统计学意义。结果 HE染色观察分析:试验组切片镜下可见心肌纤维多处断裂,细胞间质充血水肿,且伴有脂肪变性和脂质沉积;有纤维斑块形成,内部有无定型的坏死崩解物质,镜下观察呈现针形空隙,底部和边缘有肉芽组织和纤维组织,并有泡沫细胞聚集和淋巴细胞浸润;对照组心肌细胞形态正常,各动脉管腔无狭窄;CX40免疫组织化学染色结果:非冠心病猝死组显示磷酸化心肌连接蛋白40大量分布于心肌闰盘处,排列整齐并有一定的规律性;冠心病猝死组显示心肌连接蛋白40在心肌梗死部位数量减少甚至完全消失,排列散乱,分布不均匀;RT-PCR结果表明mi R-155在冠心病猝死者中的表达显著上调,且在试验组和对照组中差异有统计学意义(P<0.01)。结论在冠心病猝死患者的心肌中CX40含量减少,mi R-155显著表达,为冠心病猝死法医学鉴定提供了理论依据。 Objective To identify the expression of CX40 and miR-155 in myocardium in patients with sudden coronary death (SCD) and To explore its meaning of forensic pathology. Methods 22 cases autopsy case specimens that were diagnosed Sud- den Coronary Death as experimental group, and 10 cases autopsy case specimens that were diagnosed non-Sudden Coronary Death as control group; Cut all the wax stones into slices and then haematoxylin-eosin staining; Immunohistoehemical technique were used to detect the expression of CX40; Use the Paraffin embedding tissue mirnas rapid extraction kit to extract miRNA- 155; The expression of miRNA-155 extracted from blocks in every group was investigated by RT-PCR; Using SPSS 18.0 statistical software analysis data statistics processing, P〈0.05 showed statistically significant. Results In the experimental group: the pathologic changes of myocardi- al tissue included edema and congestion in mesenchyma, and inflammatory cells infiltration, and large area of myocardial fibers broke; Fiber plaque formation and foam cell formation and aggregation in plaque; There are areas of necrosis and collapse internal; And at the bottom of the edge with granulation tissue and fibrous tissue; Normal myocardial cells in the control group,there are no nar- row in the arterial lumen; Immunohistochemieal technique: in the control group: the expression of connexin 40 was mainly observed in intercalated disc at the end of myocardium, with less expression on cell surfaeeand in cytoplasm; In the experimental group: the number of connexin 40 reduced or even completely disappeared in the part of myocardial infarction; CX40 unevenly distributed; The expression of miRNA-155 in the sudden coronary death group was higher compared to normal myocardial group (P〈0.01). Conclu- sion The abnormal expression of CX40 and miR-155 in the sudden coronary death group provided a theoretical basis for forensic identification in the sudden death of coronary heart disease (CHD).
出处 《解剖学研究》 CAS 2016年第5期404-408,共5页 Anatomy Research
关键词 心肌连接蛋白40 猝死 动脉粥样硬化 免疫组织化学染色 CX40 Sudden death Atherosclerosis Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献10

  • 1Lloyd-Jones DM. Cardiovascular risk prediction: basic concepts, current status, and future directions [J]. Circulation, 2010, 121 (15) : 1768-1777. DOI: 10.1161/CIRCULATIONAHA.109.849166.
  • 2Jcrstad HT, Colkesen EB, Minneboo M, et al. The Systematic Coronary Risk Evaluation (SCORE) in a large UK population: 10-year follow-up in the EPIC-Norfolk prospective population study [J]. Eur J Prey Cardiol, 2015, 22 (1) : 119-126. DOI: 10.1177/2047487313503609.
  • 3Selvarajah S, Kaur G, Haniff J, et al. Comparison of the Framingham Risk Score, SCORE and WHO/ISH cardiovascular risk prediction models in an Asian population [J]. Int J Cardiol, 2014,176(1) :211-218. DOI: 10.1016/j.ijcard.2014.07.066.
  • 4Wu YF, Liu XQ, Li X, et al. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults [J]. Circulation, 2006, 114 (21) : 2217-2225. DOI: 10.1161/ CIRCULATIONAHA. 105.607499.
  • 5Liu J, Hong YL, D' Agostino RB St, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study [J]. JAMA, 2004, 291 (21) : 2591-2599. DOI: 10.1001/ jama.291.21. 2591.
  • 6Wassertheil-Smoller S, McGinn A, Allison M, et al. Improvement in stroke risk prediction: role of C-reactive protein and lipoprotein-associated phospholipase A2 in the women' s health initiative [ J ]. Int J Stroke, 2014, 9 ( 7 ) : 902-909. DOI: 10.1111 / j. 1747-4949.2012.00860.x.
  • 7Wang Y, Liu J, Wang W, et al. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study [J]. Eur J Prev Cardiol, 2015, 22 (3) : 380-388. DOI: 10.1177/2047487313516563.
  • 8Chambless LE, Cummiskey CP, Cui G. Several methods to assess improvement in risk prediction models: extension to survival analysis [ J]. Stat Med, 2011,30 ( 1 ) : 22-38. DOI: 10. 1002/sim.4026.
  • 9Leening MJG, Steyerberg EW, van Calster B, et al. Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective [ J ]. Stat Med, 2014, 33 (19) : 3415-3418. DOI: 10.1002/sim.6133.
  • 10Steyerberg EW, Vickers AJ, Cook NR, et al. Assessing the performance of prediction models: a framework for traditional and novel measures [J]. Epidemiology, 2010, 21 ( 1 ) : 128-138. DOI: 10.1097/EDE.0b013e3181 e30fb2.

共引文献5

同被引文献30

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部